SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bristol Myers Squibb Co., et al. – ‘SC TO-T’ on 10/19/20 re: MyoKardia, Inc. – ‘EX-99.(A)(1)(III)’

On:  Monday, 10/19/20, at 6:03am ET   ·   Accession #:  1140361-20-23217   ·   File #:  5-89169

Previous ‘SC TO-T’:  ‘SC TO-T/A’ on 8/8/12   ·   Next:  ‘SC TO-T/A’ on 10/30/20   ·   Latest:  ‘SC TO-T/A’ on 2/23/24   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/19/20  Bristol Myers Squibb Co.          SC TO-T               10:11M  MyoKardia, Inc.                   Edgarfilings Ltd.
          Gotham Merger Sub Inc.

Tender-Offer Statement by a Third Party   —   Sch. TO
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC TO-T     Tender-Offer Statement by a Third Party             HTML     64K 
 2: EX-99.(A)(1)(I)  Exhibit (A)(1)(I)                              HTML    537K 
 3: EX-99.(A)(1)(II)  Exhibit (A)(1)(Ii)                            HTML     99K 
 4: EX-99.(A)(1)(III)  Exhibit (A)(1)(Iii)                          HTML     32K 
 5: EX-99.(A)(1)(IV)  Exhibit (A)(1)(Iv)                            HTML     27K 
 6: EX-99.(A)(1)(V)  Exhibit (A)(1)(V)                              HTML     45K 
 7: EX-99.(A)(1)(VI)  Exhibit (A)(1)(Vi)                            HTML     38K 
 8: EX-99.(D)(2)  Exhibit (D)(2)                                    HTML     51K 
 9: EX-99.(D)(3)  Exhibit (D)(3)                                    HTML     27K 
10: EX-99.(D)(4)  Exhibit (D)(4)                                    HTML     89K 


‘EX-99.(A)(1)(III)’   —   Exhibit (A)(1)(Iii)


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
Exhibit (a)(1)(iii)
NOTICE OF GUARANTEED DELIVERY
to Tender Shares of Common Stock
of

MYOKARDIA, INC.

at
$225.00 Net Per Share
Pursuant to the Offer to Purchase
by

GOTHAM MERGER SUB INC.

a wholly owned subsidiary of
Bristol-Myers Squibb Company
THE OFFER AND WITHDRAWAL RIGHTS EXPIRE AT MIDNIGHT (NEW YORK CITY TIME), ONE MINUTE AFTER 11:59 P.M. NEW YORK CITY TIME, ON NOVEMBER 16, 2020, UNLESS THE OFFER IS EXTENDED OR
EARLIER TERMINATED.
This Notice of Guaranteed Delivery, or one substantially in the form hereof, must be used to accept the Offer (as defined below) if the certificates for shares of common stock, par value $0.0001 per share (the “Shares”), of MyoKardia, Inc., a Delaware corporation (“MyoKardia”) and any other documents required by the Letter of Transmittal (as defined below) cannot be delivered to Equiniti Trust Company, the depositary for the Offer (the “Depositary”), or the procedure for delivery by book-entry transfer cannot be completed, in each case prior to the expiration of the Offer. Such form may be delivered by facsimile transmission or mail to the Depositary. See Section 3 of the Offer to Purchase (as defined below).
The Depositary for the Offer is:

Equiniti Trust Company
By Mail:
By 5:00 p.m. NYC time on Expiration Date
Equiniti Trust Company
Shareowner Services
Voluntary Corporate Actions
P.O. Box 64858
By Facsimile Transmission:

Equiniti Trust Company
Shareowner Services
Voluntary Corporate Actions
(800) 468-9716 (phone)
(866) 734-9952 (fax)
By Hand or Overnight Courier:
By 5:00 p.m. NYC time on Expiration Date
Equiniti Trust Company
Shareowner Services
Voluntary Corporate Actions
1110 Centre Pointe Curve, Suite 101
DELIVERY OF THIS NOTICE OF GUARANTEED DELIVERY TO AN ADDRESS OR FACSIMILE NUMBER OTHER THAN AS SET FORTH ABOVE WILL NOT CONSTITUTE A VALID DELIVERY TO THE DEPOSITARY.
This Notice of Guaranteed Delivery is not to be used to guarantee signatures. If a signature on a Letter of Transmittal is required to be guaranteed by an “eligible guarantor institution” (as such term is defined in Rule 17Ad-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), under the instructions thereto, such signature guarantee must appear in the applicable space provided in the signature box on the Letter of Transmittal. Do not send share certificates with this notice. Share certificates should be sent with your Letter of Transmittal.
 C: 

 C: 
Ladies and Gentlemen:
The undersigned hereby tenders to Gotham Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Bristol-Myers Squibb company, a Delaware corporation, upon the terms and subject to the conditions set forth in the Offer to Purchase dated October 19, 2020 (as it may be amended or supplemented from time to time, the “Offer to Purchase”) and the related Letter of Transmittal (as it may be amended or supplemented from time to time, the “Letter of Transmittal” and, together with the Offer to Purchase, the “Offer”), receipt of which is hereby acknowledged, shares of common stock, par value $0.0001 per share, of MyoKardia, Inc., a Delaware corporation, pursuant to the guaranteed delivery procedure set forth in Section 3 of the Offer to Purchase.
Number of Shares Tendered:           
 
 
Check if securities will be tendered by book-entry transfer.
 
 
Name of Tendering Institution:
 
Account No.:                  
Dated:                   , 20
Name(s) of Record Holder(s)
 
                       
(please print)
 
Address(es):
 
 
 
(Zip Code)
 
 
Area Code and Telephone No(s):
 
Signature(s):
 
 
 C: 

 C: 
GUARANTEE

(Not to be used for signature guarantee)
The undersigned, a financial institution that is a member in good standing of a recognized Medallion Program approved by The Securities Transfer Association, Inc., including the Securities Transfer Agents Medallion Program (STAMP), the Stock Exchange Medallion Program (SEMP) and the New York Stock Exchange, Inc. Medallion Signature Program (MSP), or any other “eligible guarantor institution” (as such term is defined in Rule 17Ad-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), guarantees (a) that the above named person(s) “own(s)” the Shares tendered hereby within the meaning of Rule 14e-4 under the Exchange Act, (b) that such tender of Shares complies with Rule 14e-4 and (c) the delivery to the Depositary of the certificates for all such tendered Shares (or a confirmation of a book-entry transfer of such Shares into the Depositary's account at the Book-Entry Transfer Facility (as defined in the Offer to Purchase) in the case of a book-entry delivery), together with a properly completed and duly executed Letter of Transmittal (or a manually signed facsimile thereof) and with any required signature guarantee (or an Agent’s Message (as defined in the Offer to Purchase) in the case of a book-entry delivery) and any other required documents, all within two NASDAQ Global Select Market trading days of the date hereof.
 
(Name of Firm)
 
(Address)
 
(Zip Code)
 
(Authorized Signature)
 
(Name) (Please Print)
 
(Area Code and Telephone Number)
Dated:       
DO NOT SEND CERTIFICATES FOR SHARES WITH THIS NOTICE.
CERTIFICATES FOR SHARES SHOULD BE SENT WITH YOUR LETTER OF TRANSMITTAL.
 C: 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘SC TO-T’ Filing    Date    Other Filings
11/16/20
Filed on:10/19/20SC 14D9
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/17/20  Bristol-Myers Squibb Co.          SC TO-T/A              2:142K MyoKardia, Inc.                   Broadridge Fin’l So… Inc
11/04/20  Bristol-Myers Squibb Co.          SC TO-T/A              2:331K MyoKardia, Inc.                   Broadridge Fin’l So… Inc
10/30/20  Bristol-Myers Squibb Co.          SC TO-T/A              1:49K  MyoKardia, Inc.                   Broadridge Fin’l So… Inc


4 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/06/20  Bristol-Myers Squibb Co.          SC TO-C                3:178K MyoKardia, Inc.                   Broadridge Fin’l So… Inc
10/05/20  Bristol-Myers Squibb Co.          SC TO-C                8:11M  MyoKardia, Inc.                   Broadridge Fin’l So… Inc
10/05/20  MyoKardia, Inc.                   SC14D9C                3:47K  MyoKardia, Inc.                   Donnelley … Solutions/FA
10/05/20  MyoKardia, Inc.                   8-K:1,8,9  10/03/20   12:880K                                   Donnelley … Solutions/FA
Top
Filing Submission 0001140361-20-023217   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 7:38:31.1am ET